More on TXG
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $48.06 |
|
|||
| Open | $48.54 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $48.77 | ||||
| Day Low | $45.53 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,671,690 | ||||
- 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
- 10X Genomics (TXG) PT Raised to $50 at Canaccord
- 10X Genomics (TXG) PT Raised to $37 at Morgan Stanley
- 10X Genomics (TXG) PT Raised to $45 at Citi
- 10X Genomics (TXG) PT Raised to $42 at Piper Sandler
- Form 4 10x Genomics, Inc. For: Jun 22 Filed by: Saxonov Serge
- 10X Genomics (TXG) PT Raised to $40 at Barclays
- IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist
- Form 4 10x Genomics, Inc. For: Jun 16 Filed by: SULIMAN SHEHNAAZ
- 10x Genomics and Cleveland Clinic team up on bladder cancer research
Entities mentioned with TXG
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Visium Asset Management | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
